Riskpilot← Back to searchSign inGet full accessGHN Pharma Nordic AB
ABActiveOrg 5592791650Flöjelbergsgatan 12Wholesale of pharmaceutical and medical goods · NACE 4646Est. 20201-4 employees
Revenue 2025
SEK 126,6M
-22% vs 2024
EBITDA margin
10.5%
-29% vs 2024
Equity ratio
45.5%
Financial strength
Net profit 2025
SEK 10,4M
-32% vs 2024
| Revenue | SEK 126,6M | -22% |
| EBITDA | SEK 13,3M | -29% |
| Net profit | SEK 10,4M | -32% |
| Total assets | SEK 84M | +28% |
| Equity | SEK 38,2M | +13% |
| Employees | — | — |
Legal name
GHN Pharma Nordic AB
Org number
5592791650
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
28 oktober 2020
Share capital
SEK 50 000
Employees
1-4
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas två i förening av ledamöterna Firman tecknas var för sig av Sandström, Bengt Roland Sandström, Tina Madsen
Company purpose
Bolaget ska bedriva handel, marknadsföring, distribution och utveckling av produkter inom läkemedel och hälso- och sjukvård samt därmed förenlig verksamhet. Bolaget ska även ha som verksamhet att äga och förvalta fast och lös egendom samt därmed förenlig verksamhet.
Address
Flöjelbergsgatan 12
Email
infonordic@ghnpharma.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 59 940 | 136 875 | 137 046 | 161 776 | 126 576 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 6 928 | 17 109 | 13 440 | 18 713 | 13 346 |
| Depreciation & amort. | −15 | −23 | −23 | −43 | −60 |
| EBIT | 6 913 | 17 086 | 13 417 | 18 670 | 13 286 |
| Net financials | −64 | 175 | −365 | 499 | −577 |
| Profit before tax | 6 849 | 17 262 | 13 052 | 19 324 | 13 153 |
| Tax | −1 468 | −3 566 | −2 694 | −3 994 | −2 751 |
| Net profit | 5 381 | 13 696 | 10 358 | 15 330 | 10 402 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 54 497 | 70 168 | 88 704 | 65 638 | 84 024 |
| Equity | 5 431 | 17 127 | 22 484 | 33 814 | 38 216 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 49 066 | 53 041 | 66 219 | 31 824 | 45 808 |
| Total debt | 49 066 | 53 041 | 66 219 | 31 824 | 45 808 |
EBITDA margin
10.5%
This company
15.8%
Market median
-34% vs market
20212025
Equity ratio
45.5%
This company
38.2%
Market median
+19% vs market
20212025
Return on equity
27.2%
This company
18.4%
Market median
+48% vs market
20212025
Net profit margin
8.2%
This company
8.1%
Market median
+1% vs market
20212025
Asset turnover
1.51×
This company
1.12×
Market median
+35% vs market
20212025
Debt / equity
1.20×
This company
0.62×
Market median
-94% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-10-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
KI Chief Auditor | Chief Auditor | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (4) | ||
| Board of Directors | 2022 | |
| Chairman | 2022 | |
| Board of Directors | 2022 | |
| Board of Directors | 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 72% | 72% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
GHN Pharma AB
GHN Pharma Nordic AB Board members of GHN Pharma Nordic AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Kristofer Ingmar Håkansson | Chief Auditor | 0 companies |
| Tina Madsen Sandström | Board of Directors | 0 companies |
| Bengt Roland Sandström | Chairman | 0 companies |
| Nils Pontus Larsson Bergman | Board of Directors | 0 companies |
| Bo Mats Clemed Erasmie | Board of Directors | 0 companies |